India's CDSCO Tightens Oversight on GLP-1 Drugs, Warns Against Weight Loss Misuse
India's Central Drugs Standard Control Organization issued advisories against unsupervised use of semaglutide and tirzepatide for weight loss, cracking down on misleading social media promotions and unapproved compounded versions.